Vanda Pharmaceuticals Inc. (VNDA)

Vanda Pharmaceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 11, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	395	279	243	418	874	719
Market Cap Growth	33.21%	15.04%	-41.95%	-52.16%	21.63%	-17.89%
Enterprise Value	114	-89	-237	-25	481	384
Last Close Price	6.75	4.79	4.22	7.39	15.69	13.14
PE Ratio	-	-	96.77	66.65	26.37	30.79
Forward PE	-	-	-	21.74	21.94	22.59
PS Ratio	1.87	1.41	1.26	1.64	3.25	2.90
PB Ratio	0.86	0.52	0.45	0.79	1.73	1.59
P/TBV Ratio	1.11	0.66	0.57	0.82	1.80	1.67
P/FCF Ratio	-	-	-	13.36	13.73	14.38
P/OCF Ratio	-	-	18.97	13.08	13.61	13.88
EV/Sales Ratio	0.54	-	-	-	1.79	1.55
EV/EBITDA Ratio	-	-	-	-	10.69	12.74
EV/EBIT Ratio	-	-	-	-	11.41	14.08
EV/FCF Ratio	-	-	-	-	7.55	7.68
Debt / Equity Ratio	0.02	0.02	0.02	0.02	0.02	0.03
Debt / EBITDA Ratio	-	-	-	0.95	0.26	0.42
Debt / FCF Ratio	-	-	-	0.36	0.19	0.27
Asset Turnover	0.34	0.31	0.30	0.41	0.48	0.49
Inventory Turnover	6.46	7.34	11.60	21.89	22.24	19.31
Quick Ratio	2.92	4.22	4.82	5.47	6.25	6.03
Current Ratio	3.12	4.39	4.94	5.68	6.43	6.21
Return on Equity (ROE)	-16.72%	-3.49%	0.47%	1.22%	6.92%	5.40%
Return on Assets (ROA)	-12.15%	-3.90%	-1.36%	0.64%	4.68%	3.35%
Return on Capital (ROIC)	-14.75%	-4.60%	-1.60%	0.75%	5.36%	3.82%
Return on Capital Employed (ROCE)	-25.10%	-7.30%	-2.50%	1.20%	8.10%	5.80%
Earnings Yield	-21.20%	-6.77%	1.03%	1.50%	3.79%	3.25%
FCF Yield	-20.89%	-7.33%	-36.35%	7.49%	7.28%	6.96%
Buyback Yield / Dilution	-1.34%	-1.03%	-1.01%	-0.11%	-3.14%	-0.63%

Updated Oct 29, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q